article thumbnail

The top 25 supply chains and Survivor

Kinaxis

Gartner Analysts Top 10 – 2017. Peers Top 10 – 2017. Consider that Samsung has consumer electronics, visual display, semiconductor, heavy industry and biotech divisions. Once again – Peer vs Gartner. Another change needed is the vast difference between how the 169 peers vs the 38 Gartner analysts rank the companies.

Gartner 166
article thumbnail

Hyper-Collaboration in Life Sciences Creates Supply Chain Opportunities

Logility

Ecosystem Innovation, Prism First Semester 2017]. Partnerships will often comprise multiple players, including biotech, pharma, medical device and health tech companies, as well as academia, payers/providers and even regulators.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Welcome 2019

Supply Chain Shaman

The winners include small biotech companies and medical device companies investing in hospital manufacturing capabilities. In the past decade, Infor consolidated the ERP assets of Agilysis, Baan, GEAC, Intentia, and Lawson while Oracle acquired JDE and Peoplesoft. While not explicit, the driver was to develop market share. Winners and Losers.

article thumbnail

Doing Business in Belgium

QAD

2 percent annually as of 2017, making Belgium the 168 th country in the world for industrial growth rates. In addition, Belgium has become a hot spot for the growing Biotech industry with big focus on research, startup clusters and medical trials. In 2017, Belgium had $300.8 percent of its GDP in 2017. billion in imports.

Belgium 67
article thumbnail

2018 CPhI worldwide at Madrid

The Supply Chainer Report

This is an important consideration that I could say, the potential of a company with such an immense intangible knowledge is tremendous … ( 2017 FY results ). UBM is now a part of Informa , the leading B2B Information Services group. Conclusions.

article thumbnail

Risk Management in Contract Pharmaceutical Development: Contract Research Part 2

NC State SCRC

An aspect of drug development that has risen in popularity is having a contract research organization (CRO) conduct the clinical trials rather than the pharmaceutical or biotech company conducting them in house. 6, 2017, pp. CROs are under increased pressure to provide more innovative services to stay competitive and win contracts.

article thumbnail

Alternative Protein: A Food Manufacturers Guide [+ Case Study]

Unleashed

The pea protein market is also predicted to boom: in 2017, the pea protein market worldwide was worth US$32 million, and this is predicted to rise to US$176 million by 2025. Long used in Asian cuisine, tofu is increasingly popular in Western diets. The tofu market is expected to surpass US $1.2